Aggregated
No track record data- Bullish
- 2
- Hold
- 1
- Bearish
- 0
Oppenheimer
An Oppenheimer analyst with 22 tracked ratings across 10 distinct tickers has a 4.8-star track record, including a perfect 100% success rate in one category and a notable bullish count of 10 in another.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| PVLA | 2026-05-08 | buy | $210.00 | Aggregated |
| TBPH | 2026-03-05 | hold | $13.67 | Aggregated |
| LGND | 2026-02-27 | buy | $277.00 | Aggregated |
| INVA | 2026-02-26 | buy | $35.00 | Aggregated |
| LEGN | 2026-01-07 | buy | $75.00 | Aggregated |
| TBPH | 2025-12-03 | buy | $27.00 | Aggregated |
| LGND | 2025-11-03 | buy | $250.00 | Aggregated |
| MBX | 2025-09-23 | buy | $80.00 | Aggregated |
| MBXMBX BIOSCIENCES, INC. COMMON STOCK | 2025-09-23 | unknown | $80.00 | Aggregated |
| PVLAPALVELLA THERAPEUTICS, INC. COMMON STOCK | 2025-09-09 | unknown | $85.00 | Aggregated |
| LGND | 2025-09-03 | buy | $190.00 | Aggregated |
| LGNDLIGAND PHARMACEUTICALS, INC. - ORDINARY SHARES - CLASS B | 2025-09-03 | unknown | $190.00 | Aggregated |
| INVA | 2025-08-11 | buy | $35.00 | Aggregated |
| INVAINNOVIVA INC | 2025-08-11 | unknown | $35.00 | Aggregated |
| LGND | 2025-07-30 | buy | $162.00 | Aggregated |
| MBX | 2025-07-16 | buy | $38.00 | Aggregated |
| LGND | 2025-05-09 | buy | $145.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| PVLA | 1 | 2026-05-08 | Aggregated |
| TBPH | 3 | 2026-03-05 | Aggregated |
| LGND | 5 | 2026-02-27 | Aggregated |
| INVA | 2 | 2026-02-26 | Aggregated |
| LEGN | 1 | 2026-01-07 | Aggregated |
| MBX | 2 | 2025-09-23 | Aggregated |
| MBXMBX BIOSCIENCES, INC. COMMON STOCK | 2 | 2025-09-23 | Aggregated |
| PVLAPALVELLA THERAPEUTICS, INC. COMMON STOCK | 2 | 2025-09-09 | Aggregated |
| LGNDLIGAND PHARMACEUTICALS, INC. - ORDINARY SHARES - CLASS B | 2 | 2025-09-03 | Aggregated |
| INVAINNOVIVA INC | 2 | 2025-08-11 | Aggregated |